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ABSTRACT OF THE THESIS
Evaluating the Utility
of Multiple Trait Methods
for Estimating Polygenic Risk Scores
by
Jingyuan Fu
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University of California, Los Angeles, 2020
Professor Eleazar Eskin, Chair
Polygenic risk score (PRS) is a method that utilizes the effect sizes of genetic variants on a
particular disease or trait to evaluate an overall genetic risk for a certain individual. Such
effect sizes are often estimated using traditional genome-wide association study (GWAS) for
the trait of interest. There are methods developed that aim to improve the predictive power
of PRS by incorporating the genetic information from multiple related traits. One existing
popular method is MTAG, which requires GWAS summary statistics from multiple traits and
is based on strong assumptions about genetic correlation across traits. We developed some
variations of MTAG and evaluated their performance for computing PRS against GWAS,
using a variety of trait data from UK Biobank as well as simulated data.
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CHAPTER 1
Introduction
Polygenic risk scores (PRS) have been commonly used for studying genetic architecture,
and have gained increasing use for disease risk assessment [SHM16, LPE18]. They utilize
the genetic information collected from studies such as GWAS, and take into account the
estimated effects, whether small or large, of all of the single nucleotide polymorphism (SNPs)
evaluated in the study.
The effect sizes used to compute the PRS are typically estimated using genome-wide
association studies (GWAS), which fit a linear model for each SNP in the study on the
trait. However, small effects are difficult to estimate accurately using traditional GWAS,
sometimes requiring hundreds of thousands or millions of samples, in phenotypes that could
be difficult to collect, such as phenotypes directly related to conditions of biological tissue
samples.
People have been working on approaches to improve GWAS estimates by combining
information from multiple related traits, as many pairs of traits exhibit genetic correlation,
i.e. their effect sizes are correlated, and exhibit significant genetic correlation even in the
absence of any significantly associated loci. Several existing methods leverage this genetic
correlation in multiple traits to estimate variant effects from summary statistics [HLL17,
MZL18, TW18, QC17]. In particular, the Multi-Trait Analysis of GWAS (MTAG) method
has already been applied in a variety of settings [LTY17, GRA17].
However, MTAG may give biased effect size estimates when jointly analyzing large num-
bers of traits, due to limitations of the genetic correlation model, as it assumes the genetic
1
correlation across traits is identical across the genome, and that all SNPs have an effect in
all traits. However, it has been shown that the genetic correlation between traits can vary
from region to region [SMS17]. In cases where the assumption is violated, e.g. if a variant
only has an effect in a subset of the traits, MTAG may overestimate the magnitude of the
effect, with the degree of overestimation increasing with the number of traits in the analysis
[TW18]. Hence, we present several variations of the MTAG method that model multiple-
trait effects with more flexibility and could overcome the limitations of the MTAG method’s
assumption.
In this project, we assess the impact of estimating SNP effects from the MTAG model
and its variations on PRS accuracy. We evaluate the multi-trait methods’ utility for PRS
in a variety of settings, using simulated data and real data from the UK Biobank (UKB).
The phenotypes that we evaluate the models on include both anthropometric traits and
psychiatric traits that have been previously used to test the MTAG model [TW18]. The end
goal of this project is to have a comprehensive understanding of when multi-trait methods
actually improve polygenic risk scores compared to traditional GWAS based approaches,
with implications for improving phenotype prediction in a variety of settings.
2
CHAPTER 2
Methods
2.1 SNP filtering
We first introduce the SNP filter that we used in our analysis. We applied a SNP filter that
was used by Turley et. al for SNP discovery and effect size estimates [TW18]. This filter
was applied before running GWAS estimates. By applying the filter, we aim to filter out
certain regions where the effect sizes are found to be strongly inflated, such as a neuroticism-
associated inversion region in Chromosome 8.
2.2 Association testing and polygenic model for a single trait
We now describe how to perform a genome-wide association study (GWAS) at a SNP j on
a single trait t, using data from N individuals. A traditional GWAS assumes the following
linear model for the phenotype of individual i:
yi = βjtxij + ei (2.1)
where ei ∼ N(0, σ2e).
Suppose we have a vector of standardized genotypes x at SNP j at each individual, and
a vector of standardized phenotypes y for each individual. Then we may estimate the scalar
effect βj of SNP j on the phenotype t using linear regression:
βˆjt =
1
N
X>y ∼ N
(
βjt,
1
N
σ2e
)
= N (βj, v) (2.2)
3
where we have denoted v2 = σ2e/N for convenience. The variance σ
2
e may be estimated as
σˆ2e =
1
N
(y − βˆjtxj)>(y − βˆjtxj).
GWAS assumes a linear model where only one SNP has non-zero effect, so the effects
of any SNPs in LD with SNP j are also captured in βj and subsequently in βˆjt. For this
reason, βjt is used here to refer to the marginal effect of SNP j. The software that we used
for running GWAS estimates is PLINK (version 1.9) [PNT07], [Pur20].
Next, we describe the additive polygenic model used to compute a polygenic risk score
(PRS). In this model, an individual’s phenotype is simply the weighted sum of their stan-
dardized genotype at a set of SNPs, say a set of M independent SNPs. Recall that each
βj has been estimated on standardized phenotypes. Then the (standardized) phenotype for
individual i is given by
yi =
M∑
j=1
βjtxij + ei (2.3)
where ei ∼ N(0, σ2e) is Gaussian noise. It is also assumed that
∑M
j=1 βj ∼ N(0, σ2g),
with narrow heritability h2 =
σ2g
σ2g+σ
2
e
corresponding to the fraction of phenotypic variance
explained by additive SNP affects.
To estimate the PRS for an individual i from a set of M independent SNPs, we compute
yˆi =
M∑
j=1
βˆjtxij (2.4)
There are several options for choosing the set of SNPs to use in the PRS. For example,
one may use all genotyped SNPs, SNPs that are GWAS-significant, or some LD-pruned
subset of SNPs. If using non-independent SNPs as predictors for the PRS, we must apply a
correction for LD so that the summation is over the non-marginal SNP effects. Otherwise,
SNP effects will effectively be counted multiple times in the summation. There are existing
softwares that perform this correction when computing the PRS.
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2.3 Multivariate normal model for effects across multiple traits
Suppose that we have GWAS summary statistics from K traits at SNP j. This consists of
GWAS estimated effect sizes βˆj = (βˆj1, . . . , βˆjK), as well as the sample variance of these
estimates.
Also suppose that the true SNP effects across traits βj = (βj1, . . . , βjK)
> are drawn from
a multivariate normal (MVN), such that
βj ∼ N(0,Ω) (2.5)
where 0 is a vector of all zeros of appropriate dimension and Ω is the genetic covariance
matrix, such that entry ωij is proportional to the genetic correlation between traits i and j.
Note that βj is a vector of marginal SNP effects, that is, it includes the effects of other SNPs
in LD with the SNP of interest.
Suppose we then have K studies, one for each trait. Given the true effects, the GWAS
linear estimator will come from the following distribution
βˆj|βj ∼ N(βj,Σj) (2.6)
where Σj is the variance-covariance matrix for the estimated effects across studies for SNP
j, or to put in other words, the variance-covariance matrix for estimation errors for SNP j.
For each pair of traits (t, s), the entry Σt,s is proportional to the environmental correlation
across studies for this pair of trait, which may be non-zero if there is sample overlap across
studies. In practice, we estimate Σˆj using the following steps done by Turley et. al [TW18].
For a trait t with a study size of Nt at SNP j, Σˆt,t,j = σ
2
et/Nt,j. For a set of two traits t, s
with study sizes of Nt and Ns respectively at SNP j, Σˆt,s,j = σetσes/
√
Nt,jNs,j. Note that
the study size N ’s could vary across SNPs for any specific trait.
Here, σ2et and σetσes are variance and covariance due to a sample overlap, that can be
estimated from LD score regression intercepts [BF15].
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In addition to LD score regression covariance intercepts that are used in the multi-trait
analysis, we also collected genetic covariance, genetic correlation and heritability of each
trait using LD score regression.
In practice, the variance-covariance matrix of effect size distribution, Ωˆ, is estimated
using methods of moments described in Turley et. al [TW18].
Ωˆ =
1
M
M∑
j=1
(
βˆjβˆ
′
j − Σˆj
)
(2.7)
where βˆj is the GWAS estimates of effect sizes for SNP j.
2.4 Multi-trait estimator for effect size, assuming identical genetic
covariance across the genome
Here we present the multi-trait linear estimator derived by Turley et al. for estimating effects
from GWAS summary statistics, assuming all of the effect sizes share the same variance-
covariance matrix Ω [TW18].
Suppose we have GWAS summary statistics for a trait of interest and additional related
traits, as well as covariance matrices Ω and Σ. For purposes of the derivation, we assume
that the true values of Ω and Σ are known. We call the trait of interest the primary trait,
and the additional traits as auxiliary traits. Denote the GWAS effect sizes from K traits as
βˆj1, βˆj2, ..., βˆjK . [TW18] derive an estimator bMTAG for the effect in the primary trait β1:
bMTAG =
(
ω1
ω11
)> (
Ω− 1
ω11
ω1ω
>
1 + Σj
)−1
βˆ(
ω1
ω11
)> (
Ω− 1
ω11
ω1ω>1 + Σj
)−1 (
ω1
ω11
) (2.8)
Note that MTAG estimates the effects of all traits in the analysis jointly, but for consis-
tency with other methods we test, we use the primary/auxiliary trait notation.
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2.5 Two component mixture models for effects across traits
In the previous sections, we assume the true SNP effects are drawn from the same distribution
across the genome, so that all SNPs have some effect in all traits. We now consider models
where the true SNP effects across traits are drawn from a Gaussian mixture model with two
components.
Let βj = (βj1, . . . , βjK)
> denote the effects of SNP j in traits 1, . . . , K. Let pi0 and pi1
be the mixing weights of each component, such that pi0 = 1 − pi1, and let γj be a latent
variable for which component SNP j was drawn from. Say the trait of interest t1 is the first
entry in β, which we will refer to the primary trait, and other traits as auxiliary traits. The
generative model for the true effects at a SNP is as follows.
γj ∼ Bernoulli(pi)
βj|γj = 0 ∼ N (0,Ω0)
βj|γj = 1 ∼ N (0,Ω1)
where Ω0 is a K by K matrix chosen from one of the options described below, and Ω1 is
the genetic covariance matrix,
Ω1 =

τ 21 ρ12τ1τ2 · · · ρ1kτ1τk
ρ12τ1τ2 τ
2
2 · · · ρ2kτ2τk
...
...
. . .
...
ρ1kτ1τk ρ2kτ2τk · · · τ 2k

Ω1 corresponds to the classic polygenic model with full genetic correlation, estimated
using Eq. 2.7, while Ω0 contains a subset of entries of Ω1 reflecting our assumptions about
the relationships between traits in the analysis. The mixing parameters pi are estimated by
expectation-maximization (EM).
We test four options for Ω0 each corresponding to a different possible GMM, described
below.
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• If we assume the primary trait has an effect and there is no effect among other traits
(we will refer to the corresponding model as GMM A):
Ω0a =

τ 21 0 · · · 0
0  · · · 0
...
...
. . .
...
0 0 · · · 

• If we assume the primary trait is sometimes sparse, but correlation amongst the aux-
illary traits is the same for all SNPs (GMM B):
Ω0b =

 0 · · · 0
0 τ 22 · · · ρ2kτ2τk
...
...
. . .
...
0 ρ2kτ2τk · · · τ 2k

• If we assume there is no sparsity in effect sizes, but the primary trait is sometimes
uncorrelated with the auxillary traits (GMM C):
Ω0c =

τ 21 0 · · · 0
0 τ 22 · · · ρ2kτ2τk
...
...
. . .
...
0 ρ2kτ2τk · · · τ 2k

• If we assume there is no sparsity in effect sizes, but effect sizes are sometimes completely
independent in all traits (GMM D):
Ω0d =

τ 21 0 · · · 0
0 τ 22 · · · 0
...
...
. . .
...
0 0 · · · τ 2k

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2.5.1 Model fitting
The mixture weights for these GMMs are estimated using Expectation-Maximization (EM).
We describe the procedure here. Assuming we are given βˆj for j = 1, . . . ,M . We use
N(βˆj|0,A) to denote the density at βˆj of a centered multivariate normal distribution with
covariance matrix A.
In the E step, we compute membership assignment for each SNP based on our current
estimates for the mixture weights.
p(γj = 0|βˆj,Ω0,Σj)← N(βˆj|0,Ω0 + Σj)∑1
c=0N(βˆj|0,Ωc + Σj)pic
(2.9)
for j = 1, . . . ,M .
In the M step, we total the fraction of SNPs assigned to each component to get the
mixture weights. The M step becomes
pi0 ←
∑M
j=1 p(γj = 0|βˆj,Ω0,Σj)
M
(2.10)
for j = 1, . . . ,M .
We alternate between the E and M steps until convergence. These EM updates assume
that each SNP is an independent sample from the mixture distribution, so they should be
computed over an LD-pruned subset of all available SNPs.
2.6 Stratifying SNPs by LD score and MAF
The four GMMs in the previous section base both covariance components on the GWAS
estimated effect sizes and covariance intercepts across all available SNPs. As an alternative
approach, we also tested a model where each component corresponds to a different subset of
SNPs, stratified by minor allele frequency (MAF) and LD score. Rare SNPs tend to have a
9
different effect size distribution than common SNPs, and SNP marginal effects include the
effects of any SNPs in strong LD.
We tested a model with 4 bins. In this model, we split SNPs into top 50% or bottom
50% by LD score, and MAF < 0.1 or MAF ≥ 0.1, and split the summary statistics according
to the bins. For each bin, we munged the corresponding summary statistics and obtained
estimates of genetic covariance, covariance intercepts, genetic correlation and heritability
using LDSC separately [BL15, BF15]. Then, we applied MTAG to each bin. We estimated
the effect size variance-covariance matrix separately for each bin using Eq. 2.7, except now
we are only using SNPs in that bin rather than using all of the SNPs in the analysis. We
then computed the MTAG effect size estimators using Eq. 2.8 for each bin, and combined
those effect size estimators for all of the SNPs.
2.7 Computing polygenic risk scores with correction for LD
In Eq. 2.3, we assumed we had an independent set of SNPs to compute the PRS. However in
practice, there is widespread correlation between SNPs in the genome, i.e. linkage disequilib-
rium (LD). To account for LD, one may either select a subset of approximately independent
SNPs using LD pruning and thresholding by GWAS p-value, or adjust the marginal SNP
effects for LD before computing PRS.
We use LDpred (version 1.06) to adjust estimates of marginal SNP effects for LD before
computing the PRS [VYF15], as in [TW18]. We use a random sample of 5,000 individuals
as an LD reference panel. We set the LD radius to be 150 when generating LDpred SNP
weights. We assume an infinitesimal model in LDpred, meaning that the fraction of causal
SNPs assumed by LDpred is 1. We apply LDpred to GWAS, MTAG, and our five additional
models for the anthropometric and psychiatric traits.
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2.8 Validating method performance using simulated effect sizes
from bivariate normal distribution
To validate the multi-trait methods’ performance on simulated datasets, we adopted similar
simulation settings to Turley et. al [TW18], except that we only generated effect sizes
from a bivariate normal distribution model rather than a spike-and-slab model. In short,
we generated 100,000 length-two ”true” effect size vectors βj using the bivariate normal
distribution setting. The distribution has variance one and correlation rβ, and the effect sizes
are drawn from this distribution with mean zero and variance covariance matrix Ωnormal using
2.11. We also generated z-statistics, Zj, where for each SNP j, we add estimation errors
to the true effect size vectors, and then divide the estimates by the standard deviation of
estimation error. The estimation error is drawn from a bivariate normal distribution with
mean zero and variance-covariance matrix Σ, which is calculated using Eq. 2.12. We then
generated an estimate of Σ, Σˆ, by adding independent, normally distributed noise to Σ.
We then estimated Ωˆ using the methods of moments procedure in Eq. 2.7 and generated
MTAG estimates and standard errors for each SNP and for each trait. We computed GMM
estimates using GMM A method.
Ωnormal =
 1 rβ
rβ 1
 (2.11)
Σ = CΣLDC (2.12)
where C =

√
1
χ21−1 0
0
√
1
χ22−1
 and ΣLD ≡
 1 rε
rε 1

Here, we fixed rε to be 0.3, where rβ, χ
2
1 and χ
2
2 were changed in different settings. This
equation is to capture the effect of estimation error on Σˆ [TW18].
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CHAPTER 3
Results
3.1 UK Biobank Results
3.1.1 Genetic correlation and trait selection
3.1.1.1 UK Biobank anthropometric traits
We chose a number of anthropometric traits in the UK Biobank and estimated the genetic
correlation matrix using LD score regression. The genetic correlation matrix is estimated
using in total 225268 SNPs, shown in Table. 3.1.
We selected the four sets of traits that we proceeded to analyze. The sets were (1) arm
fat percentage in left arm, trunk fat percentage and waist circumference; (2) automated
pulse measurement and pulse rate (during blood-pressure measurement); (3) automated
pulse measurement and standing height; and (4) standing height, seated height, and systolic
blood pressure. Note that we refer to the ”pulse rate (during blood-pressure measurement)”
trait as manual pulse for convenience. These four sets of traits are chosen to represent four
different scenarios in multi-trait analysis respectively: strong positive genetic correlation for
three traits with large datasets (set 1), strong positive genetic correlation for two traits with
varying sizes of datasets (set 2), weak genetic correlation for two traits with large datasets
(set 3), and a combination of strong and weak correlations with varying sizes of datasets (set
4) (Table. 3.1) [BF15]. The dataset sample sizes are shown in later sections (Table. 3.3).
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3.1.1.2 UK Biobank psychiatric traits
Besides analyzing anthropometric traits in UK Biobank (UKB), we also analyzed the same
set of traits as Turley et. al have analyzed in their paper [TW18]. They analyzed three
psychiatric traits: depression, neuroticism and subjective well-being, using several large
cohorts of data from UK Biobank, 23andMe and SSGAC. As we are only using UK Biobank
traits, our samples do not have a large proportion of overlap with their samples. Therefore,
we compared GWAS estimated effect sizes that we computed using UK Biobank dataset
and the GWAS effect size estimates generated from the dataset that Turley group used.
After testing for correlation (Fig. 5.1A and 5.1B), we decided to use only depression and
neuroticism for our evaluation, as the GWAS estimated effect sizes of subjective well-being
dataset did not correlate well with those computed by Turley group. It could be because
there are multiple measures of subjective well-being, and 23andMe dataset uses different
measures than UKB, making the UKB dataset alone not representative of the whole cohort
in their analysis.
We continued to compute the genetic correlation between depression and neuroticism,
which is 0.8079 (with a standard error of 0.0251), estimated using in total 225268 SNPs.
In future sections, we use abbreviations of the trait names to represent the actual trait
for both anthropometric and psychiatric traits. The corresponding traits and descriptions
are in (Table. 3.2)
3.1.2 Sampling data and stratifying SNPs
All traits used in these experiments had on the order of 3 to 4 million individuals with non-
missing phenotype values, except for manual pulse and systolic blood pressure, which had
on the order of 50k individuals. For the following experiments, we only used white British
individuals in the UK Biobank. We randomly subsampled 200k individuals from the UK
Biobank to use as a GWAS cohort, and 10k individuals for whom we computed PRS from
13
the different methods, such that there was no overlap between the two cohorts. Note that we
did not take missing phenotypes into account when sampling, so the final GWAS sizes are
proportionate the the original sample sizes. We used LDpred to estimate PRS from effect
sizes [VYF15],[TW18].
After excluding any missing data from the samples, the number of final individual counts
for each trait is in Table. 3.4 and 3.3, where systolic blood pressure and manual pulse have
¡20k samples, while the other traits have 190k to 200k samples.
After we stratify the SNPs into 4 bins using LD score and MAF, the number of SNPs
in each bins are shown in Table. 3.5, and the gene correlation matrices and heritability
estimates are shown in supplement (Table. 5.1, 5.2, 5.3, 5.4, 5.5)
3.1.3 Evaluation of PRS predictions
We applied GWAS, MTAG, four GMM models, and the 4 bin method to four sets of an-
thropometric traits and one set of psychiatric traits in the UK Biobank chosen to represent
different scenarios for multi-trait analysis.
We then computed the Pearson correlation between the PRS from each method and the
true phenotypes of the PRS cohort. We computed incremental r2, the proportion increase
in r2 between the PRS estimated using the seven models, compared to prediction using
linear model with covariates only (Fig. 3.1). We also computed incremental adjusted r2,
incremental r2 corrected for additional number of predictors compared to covariate-only
linear model (Fig. 3.2). We found that GMMs A-D typically performed similarly to each
other, with GMM B sometimes outperforming other GMM methods. The 4 bin model’s
performance also varied dramatically in different traits. We also noted that MTAG was
consistently not the worst, and that its performance relative to GWAS was strongest for
predicting manual pulse using automated pulse (Fig. 3.2B), though it did underperform
GWAS for both traits in the pulse and height set. We suspect that MTAG is mainly useful
14
in situations where GWAS in the trait of interest is underpowered, but otherwise performs
comparably to GWAS, or worse if the traits are weakly correlated.
We also computed the same metrics for the set of psychiatric traits that we are evaluating
our methods on (Fig. 3.3).
The genetic correlation matrices calculated in the 4 bins model are listed in Supplement
(Table. 5.1, 5.2, 5.3, 5.4 and 5.5). As shown in Table. 5.1 and 5.3, calculation of genetic
correlation for traits with small sample sizes failed in those two bins, because the h2 (heri-
tability) estimates are negative in those cases. As genetic correlation between two traits are
calculated using genetic covariance and h2, we also provided the tables of genetic covariance
and h2 in the Supplement (Table. 5.6, 5.7, 5.8, 5.9, 5.10, 5.11 and 5.12).
15
(A) armfat percent, trunkfat percent, waistc (B) pulse automated, pulse manual
(C) pulse automated, height (D) height, height seated, sysbp
Figure 3.1: Predictive power of mixture models, GWAS, and MTAG on four sets of anthropometric traits.
Polygenic risk scores (PRS) were computed using one of five mixture models, GWAS, or MTAG effect
size estimates. Incremental r2 is proportion increase in r2 between the PRS and observed phenotypes,
compared to prediction using linear model with covariates only. Note that for sysbp, the PRS from
GMM B estimates did not run successfully during LDpred prediction step, because the mean χ2 statistic
is too small.
16
(A) armfat percent, trunkfat percent, waistc (B) pulse automated, pulse manual
(C) pulse automated, height (D) height, height seated, sysbp
Figure 3.2: Predictive power of mixture models, GWAS, and MTAG on four sets of anthropometric traits.
Polygenic risk scores (PRS) were computed using one of five mixture models, GWAS, or MTAG effect
size estimates. Adjusted incremental r2 is incremental r2 corrected for additional number of predictors
compared to covariate-only linear model. Note that for sysbp, the PRS from GMM B estimates did not
run successfully during LDpred prediction step, because the mean χ2 statistic is too small.
17
(A) Incremental R2 for depression and neuroticism
(B) Incremental adjusted R2 for depression and
neuroticism
Figure 3.3: Predictive power of mixture models, GWAS, and MTAG on a set of psychiatric traits,
depression and neuroticism. Polygenic risk scores (PRS) were computed using one of five mixture
models, GWAS, or MTAG effect size estimates. Adjusted incremental r2 is incremental r2 corrected for
additional number of predictors compared to covariate-only linear model.
3.2 MSE comparison in simulation
We generated the effect sizes, effect size distribution and estimation errors using the same
parameter settings as Turley et. al and computed the theoretical mean squared error (MSE)
using the same formula as Turley et. al for GWAS and MTAG [TW18] (Fig: 3.4A and 3.4B).
We also computed the actual MSE for the GWAS, MTAG and GMM A method for the same
simulation data (Fig: 3.4C).
The MTAG simulation results replicate those shown in Turley et. al [TW18], showing
a trend of lower MSE when there is higher genetic correlation among traits and when χ2 is
higher (indicating higher heritability and larger estimation sample size). The MSE’s from
18
GMM method are much lower than the MSE’s from GWAS method or MTAG method.
This indicates that if our assumptions of effect size distribution are correct, the multi-trait
methods should perform in the way that we expected, and that GMM method predicts with
much higher accuracy than the other methods in simulated data.
(A) Ratio of actual MSE of MTAG estimates to
MSE of GWAS estimates
(B) Ratio of theoretical MSE of MTAG estimates
to MSE of GWAS estimates
(C) Ratio of actual MSE of GMM estimates to MSE
of GWAS estimates
Figure 3.4: MSE computed from simulation results
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Table 3.2: List of traits used in the analysis and description
Trait abbreviation Shorter abbreviation Description
armfat percent armfat% arm fat percentage, left arm
height height standing height
height seated height s seated height
pulse automated pulse a pulse rate, automated reading
pulse manual pulse m pulse rate, during blood-pressure measurement
sysbp sysbp systolic blood pressure, manual reading
trunkfat percent trunkfat% trunk fat percentage
waistc waistc waist circumference
DEP DEP depression
NEU NEU neuroticism
Table 3.3: Number of final individual counts (sizes of GWAS cohort) for each anthropometric trait in
the 200k randomly sampled individuals from UK Biobank
Trait armfat% height height s pulse a pulse m sysbp trunkfat% waistc
Num ind 196573 199573 199576 188947 18805 18805 196521 199671
Table 3.4: Number of final individual counts (sizes of GWAS cohort) for each psychiatric trait in the
200k randomly sampled individuals from UK Biobank
Trait DEP NEU
Num ind 180390 162694
21
Table 3.5: SNP bins used for the stratified method, partitioned by LD score and MAF (upper bounds
exclusive) LDSC calculated from the filtered SNPs
Bin LD score quartile range MAF range Number of SNPs
1 0 - 50 0 - 0.1 66071
2 50 - 100 0 - 0.1 38936
3 0 - 50 0.1 - 0.5 46544
4 50 - 100 0.1 - 0.5 73717
22
CHAPTER 4
Discussion
Through applying GWAS and various multi-trait approaches to UK Biobank anthropometric
and psychiatric traits and simulated datasets, we aim to assess whether the SNP effect sizes
estimated by any of the approaches would improve the predictive power of polygenic risk
score.
From the UK Biobank results, we observe that the 4 bins model performs with a high
similarity to MTAG than to GWAS or other multi-trait methods. We also observe that the
GMM methods’ performance have an overall similar pattern to GWAS method and other
GMM methods, with GMM B sometimes having a better performance than other GMM
methods. We realize that in traits that are highly genetically correlated and when one of
the traits has a small sample size, such as in the automated pulse and manual pulse set
(Fig. 3.2B), both the 4 bins method and MTAG method boost the predictive power more
strongly than other GMM methods for the trait. However, when the two traits have low
or negative genetic correlation, such as in automated pulse and height set, and in standing
height, seated height and systolic blood pressure set (Fig. 3.2C and 3.2D), 4 bins and MTAG
methods have the lowest performance compared to other methods. In the cases where the
traits have high genetic correlation and the sample sizes of the two traits are comparably
large, we cannot determine which one of the methods has the highest performance, as GWAS
method outperforms other methods in some cases (Fig. 3.2A), while the 4 bins and MTAG
methods outperform in other cases (Fig. 3.3B). Since we tested on various sets of traits that
represent different scenarios, including the set of traits that was analysed in Turley et. al
23
[TW18], we conclude that multi-trait method does not perform consistently better in all of
the scenarios than GWAS.
We suspect the reason that 4 bins and MTAG methods are similar in performance could
be because SNPs in one of the bins provide the most information and have relatively larger
effect sizes, making the effect size estimates of that specific bin representative of the genome.
In order to further validate our conclusion, performing similar experiments using different
sub-sample sizes and observing potential trends in each methods’ performance with respect
to sample size will provide useful insights. In addition, for the 4 bins method, performing a
controlled experiment that involves random stratification of 4 bins, and comparing the PRS
generated from SNPs from any of the 4 bins with the overall PRS could also be helpful.
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CHAPTER 5
Supplement
5.1 LDSC genetic correlation in 4 bins model
The genetic correlation matrices calculated in the 4 bins model are listed in (Table. 5.1, 5.2,
5.3, 5.4 and 5.5)
5.2 LDSC genetic covariance and heritability estimation for all
SNPs and in 4 bins model
The genetic covariance and heritability tables calculated for all SNPs and for SNPs in the 4
bins model are listed in (Table. 5.6, 5.7, 5.8, 5.9, 5.10, 5.11 and 5.12)
5.3 GWAS effect size estimates correlations for UKB psychiatric
traits
The GWAS effect size estimates for depression and neuroticism are calculated from UKB
psychiatric traits, and they are referred to as DEP first instance GWAS and NEU first
instance GWAS. We compare those estimates with the GWAS effect size estimates for same
traits using the large cohort analysed by Turley et. al [TW18] [LOB16]. The results are
shown in Fig. 5.1.
25
(A) GWAS effect size estimates correlation between
UKB depression dataset and depression dataset
from previous group
(B) GWAS effect size estimates correlation between
UKB neuroticism dataset and neuroticism dataset
from previous group
Figure 5.1: GWAS effect size estimates correlations for UKB psychiatric traits. Red dashed line corre-
sponds to y = x line and blue line is the regression trend line for the dataset
26
5.4 Proportion of SNP effect size assignments in GMM models
The proportion of SNP effect size assignments for each trait in each GMM model after EM
steps are shown in Table. 5.13. pi0 is the proportion of SNP assignments to distribution
component with variance-covariance matrix Ω0, and pi1 is the proportion of SNP effect size
assignments to distribution component with variance-covariance matrix Ω1.
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Table 5.5: Genetic correlation (standard error) table between UKBB psychiatric traits, stratified into 4
bins by LD score and MAF. LDSC calculated from the filtered SNPs.
(a) SNPs with MAF 0-0.1 and LD score in the 0-50th percentile.
DEP NEU
DEP 1.000 0.987(0.121)
NEU 0.987(0.121) 1.000
(b) SNPs with MAF 0-0.1 and LD score in the 50-100th percentile.
DEP NEU
DEP 1.000 0.896(0.074)
NEU 0.896(0.074) 1.000
(c) SNPs with MAF 0.1-0.5 and LD score in the 0-50th percentile.
DEP NEU
DEP 1.000 0.9(0.145)
NEU 0.9(0.145) 1.000
(d) SNPs with MAF 0.1-0.5 and LD score in the 50-100th percentile.
DEP NEU
DEP 1.000 0.778(0.052)
NEU 0.778(0.052) 1.000
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Table 5.7: Genetic covariance and heritability (standard error) table between UKBB psychiatric traits
(no bins). LDSC calculated from the filtered SNPs
DEP NEU
DEP 0.075(0.006) 0.07(0.005)
NEU 0.07(0.005) 0.1(0.007)
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Table 5.12: Genetic covariance and heritability (standard error) table between UKBB psychiatric traits,
stratified into 4 bins by LD score and MAF. LDSC calculated from the filtered SNPs. Diagonal entries
are heritability estimates for each trait, and off-diagonal entries are genetic covariance estimates for
each pair of traits.
(a) SNPs with MAF 0-0.1 and LD score in the 0-50th percentile.
DEP NEU
DEP 0.065(0.018) 0.064(0.016)
NEU 0.064(0.016) 0.066(0.021)
(b) SNPs with MAF 0-0.1 and LD score in the 50-100th percentile.
DEP NEU
DEP 0.06(0.013) 0.056(0.011)
NEU 0.056(0.011) 0.066(0.012)
(c) SNPs with MAF 0.1-0.5 and LD score in the 0-50th percentile.
DEP NEU
DEP 0.052(0.021) 0.072(0.019)
NEU 0.072(0.019) 0.125(0.025)
(d) SNPs with MAF 0.1-0.5 and LD score in the 50-100th percentile.
DEP NEU
DEP 0.072(0.009) 0.061(0.009)
NEU 0.061(0.009) 0.086(0.013)
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(a) Proportion of assignments in GMM models for anthropometric trait set (1)
Model GMM A GMM B GMM C GMM D
Assignments pi0 pi1 pi0 pi1 pi0 pi1 pi0 pi1
armfat% 0.006 0.994 0.022 0.978 0.006 0.994 0.008 0.992
trunkfat% 0.049 0.951 0.004 0.996 0.008 0.992 0.008 0.992
waistc 0.061 0.939 0.021 0.979 0.007 0.993 0.008 0.992
(b) Proportion of assignments in GMM models for anthropometric trait set (2)
Model GMM A GMM B GMM C GMM D
Assignments pi0 pi1 pi0 pi1 pi0 pi1 pi0 pi1
pulse a 0.236 0.764 0.953 0.047 0.044 0.956 0.044 0.956
pulse m 0.953 0.047 0.236 0.764 0.044 0.956 0.044 0.956
(c) Proportion of assignments in GMM models for anthropometric trait set (3)
Model GMM A GMM B GMM C GMM D
Assignments pi0 pi1 pi0 pi1 pi0 pi1 pi0 pi1
pulse a 0.830 0.170 0.880 0.120 0.614 0.386 0.614 0.386
height 0.880 0.120 0.830 0.170 0.614 0.386 0.614 0.386
(d) Proportion of assignments in GMM models for anthropometric trait set (4)
Model GMM A GMM B GMM C GMM D
Assignments pi0 pi1 pi0 pi1 pi0 pi1 pi0 pi1
height 0.830 0.170 0.880 0.120 0.614 0.386 0.614 0.386
height s 0.880 0.120 0.830 0.170 0.614 0.386 0.614 0.386
sysbp 0.929 0.071 0.988 0.012 0.214 0.786 0.001 0.999
(e) Proportion of assignments in GMM models for psychiatric trait set
Model GMM A GMM B GMM C GMM D
Assignments pi0 pi1 pi0 pi1 pi0 pi1 pi0 pi1
DEP 0.292 0.708 0.424 0.576 0.047 0.953 0.047 0.953
NEU 0.424 0.576 0.292 0.708 0.047 0.953 0.047 0.953
Table 5.13: Proportions of component assignments in four GMM models for all of the trait sets
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